The global demand for advanced carcinoid tumor treatments is witnessing a profound acceleration, as evidenced by the market's current valuation of USD 1.3 billion in 2023. With the compounded ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

Improved understanding of the etiology of carcinoid-tumor-related fibrosis may lead to better treatments for this condition than those we currently have. Fibrosis that develops either local to or ...

Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness, improved diagnosis and treatment. Biomarkers such as ...

Jennifer Chan, MD, MPH, discussed the recent FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine ...

We decided to stop all antitumor treatment and to continue only with best supportive care. The patient died 31 months after the initial diagnosis. Patients with pulmonary carcinoid tumors can be ...

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

The Carcinoid Cancer Foundation is an American organisation that encourages and supports education and research on carcinoid and related neuroendocrine cancers. Its website has information about ...

The global demand for advanced carcinoid tumor treatments is witnessing a profound acceleration, as evidenced by the market's current valuation of USD 1.3 billion in 2023. With the compounded annual ...